Faculty Opinions recommendation of Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.

Author(s):  
Fanny Lanternier
Mycoses ◽  
2013 ◽  
Vol 57 (1) ◽  
pp. 49-55 ◽  
Author(s):  
Russell E. Lewis ◽  
Sarah P. Georgiadou ◽  
Fotis Sampsonas ◽  
George Chamilos ◽  
Dimitrios P. Kontoyiannis

2019 ◽  
Author(s):  
A Tufman ◽  
S Schneiderbauer ◽  
D Kauffmann-Guerrero ◽  
F Manapov ◽  
C Schneider ◽  
...  

2020 ◽  
Vol 138 ◽  
pp. e905-e912
Author(s):  
Xingwang Zhou ◽  
Xiaodong Niu ◽  
Junhong Li ◽  
Shuxin Zhang ◽  
Wanchun Yang ◽  
...  

Perfusion ◽  
2007 ◽  
Vol 22 (4) ◽  
pp. 225-229 ◽  
Author(s):  
Kari Wagner ◽  
Ivar Risnes ◽  
Michael Abdelnoor ◽  
Harald M. Karlsen ◽  
Jan Ludvig Svennevig

Background. Serious heart failure may be treated with extracorporeal membrane oxygenation (ECMO) when other treatment fails. The aim of the present study was to analyse preoperative risk factors of early mortality in patients treated with veno-arterial (VA)-ECMO. Methods. We studied a total of 18 possible risk factors in 80 patients with severe cardiac insufficiency treated with VA-ECMO. All consecutive cases treated at our institution between Sept.1990 and May 2006 were included. Univariate analysis and multiple logistic regression analysis were performed on 16 risk factors. The endpoint was early mortality (any death within 30 days of ECMO treatment). Results. Thirty patients (37.5%) died within 30 days. Age, gender, cause of cardiac failure, pre-ECMO treatment (ventilator, NO, IABP) did not significantly influence early mortality. A higher SvO2 was associated with survival and remained significant in the multivariate analysis. Conclusion. Treatment with VA-ECMO in patients with severe cardiac failure may save lives. It is, however, difficult to predict outcome. In this study, only SvO2 values prior to ECMO were positively associated with survival. Perfusion (2007) 22, 225—229.


2018 ◽  
Vol 6 (12) ◽  
pp. 232596711881331 ◽  
Author(s):  
Arthur H. Owora ◽  
Brittany L. Kmush ◽  
Bhavneet Walia ◽  
Shane Sanders

Background: Multiple risks predispose professional football players to adverse health outcomes and, in extreme cases, early death; however, our understanding of etiological risk factors related to early mortality is limited. Purpose: To identify etiological risk factors associated with all-cause and cause-specific mortality among National Football League (NFL) players. Study Design: Systematic review; Level of evidence, 3. Methods: Articles examining all-cause and cause-specific mortality risk factors among previous NFL players were identified by systematically searching: PubMed, PsycINFO, Web of Science, and Google Scholar from 1990 to 2017. Study eligibility and quality were evaluated using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Results: A total of 801 nonduplicated studies were identified through our search strategy. Of these, 9 studies examining 11 different risk factors were included in the systematic review. Overall, the risk of all-cause and cause-specific mortality was lower among NFL players than among the general male population in the United States. Nonwhite athletes, those in power positions, and those with a high playing-time body mass index (≥30 kg/m2) were associated with elevated all-cause and cardiovascular mortality risks. Conclusion: Methodological issues associated with the examined all-cause and cause-specific mortality risk factors preclude a definitive conclusion of etiological protective or risk effects. Comparison groups less prone to selection bias (“healthy worker effect”) and a life-course approach to the evaluation of suspected risk factors are warranted to identify etiological factors associated with early mortality among NFL players.


2020 ◽  
Vol 55 (10) ◽  
pp. 2233-2237
Author(s):  
Saloua Ammar ◽  
Sahla Sellami ◽  
Imen Sellami ◽  
Amel Ben Hamad ◽  
Manar Hbaieb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document